Key points are not available for this paper at this time.
Background Glioblastoma (GBM) is a brain tumor with poor prognosis. Dexmedetomidine (Dex) regulates the biological behaviors of tumor cells to accelerate or decelerate cancer progression.
Zhu et al. (Wed,) studied this question.